News + Filings Holdings
All
13F
13D/G
Other
|
|
VHCP Management III, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 4,674 shares
@ $11.98, valued at
$56k
Bought 170,292 shares
@ $11.67, valued at
$2M
|
|
| 10/11/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 28,900 shares
@ $12, valued at
$346.8k
Bought 80,314 shares
@ $11.89, valued at
$954.9k
Bought 25,000 shares
@ $11.85, valued at
$296.3k
|
|
| 10/06/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 223,100 shares
@ $11.81, valued at
$2.6M
|
|
| 10/03/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 168,187 shares
@ $9.92, valued at
$1.7M
Bought 268,736 shares
@ $11.27, valued at
$3M
|
|
| 09/28/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 395,614 shares
@ $8.56, valued at
$3.4M
Bought 115,000 shares
@ $9.38, valued at
$1.1M
Bought 76,600 shares
@ $9.92, valued at
$759.9k
|
|
| 09/07/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 63,030 shares
@ $12.76, valued at
$804.3k
Bought 150,223 shares
@ $11.43, valued at
$1.7M
Bought 473,459 shares
@ $11.4, valued at
$5.4M
|
|
| 09/01/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 50,000 shares
@ $12.2, valued at
$610k
|
|
| 08/02/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 18,900 shares
@ $9.21, valued at
$174.1k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 1,500,000 shares
@ $7.54, valued at
$11.3M
|
|
| 05/28/2020 |
4
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 309,453 shares
@ $8.79, valued at
$2.7M
Bought 390,547 shares
@ $9.78, valued at
$3.8M
Bought 125,162 shares
@ $7.23, valued at
$904.9k
Bought 277,000 shares
@ $7.92, valued at
$2.2M
Bought 27,763 shares
@ $7.79, valued at
$216.3k
Bought 173,711 shares
@ $8.87, valued at
$1.5M
|
|
| 12/16/2019 |
4
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Bought 400,000 shares
@ $34.5, valued at
$13.8M
|
|
| 10/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2019 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 500,000 shares
@ $28.75, valued at
$14.4M
|
|
| 03/14/2019 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 142,857 shares
@ $0.7, valued at
$100k
|
|
| 09/17/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $1.1888, valued at
$89.2k
Bought 75,000 shares
@ $1.23, valued at
$92.3k
Bought 60,000 shares
@ $1.1824, valued at
$70.9k
|
|
| 09/12/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 200,000 shares
@ $1.2182, valued at
$243.6k
Bought 200,000 shares
@ $1.1442, valued at
$228.8k
Bought 75,000 shares
@ $1.1455, valued at
$85.9k
|
|
| 09/07/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.8465, valued at
$42.3k
Bought 50,000 shares
@ $0.8419, valued at
$42.1k
Bought 60,000 shares
@ $0.8957, valued at
$53.7k
|
|
|
|